Medical Research & Development Fund for Health Services Bnai Zion Medical Center
Patent Applications and Registrations
Patent applications and USPTO patent grants for Medical Research & Development Fund for Health Services Bnai Zion Medical Center.The latest application filed is for "semaphorin 3a for treatment and prognosis of systemic lupus erythematosus".
- Medical Research & Development Fund for Health Services Bnai Zion Medical Center - Haifa IL
| Patent | Date |
|---|---|
| Semaphorin 3A for treatment and assessment of severity of inflammatory bowel disease Grant 10,736,939 - Vadasz , et al. A | 2020-08-11 |
| Semaphorin 3A for treatment and assessment of severity of Asthma Grant 10,568,932 - Vadasz , et al. Feb | 2020-02-25 |
| Semaphorin 3a For Treatment And Prognosis Of Systemic Lupus Erythematosus App 20190000921 - Vadasz; Zahava ; et al. | 2019-01-03 |
| Semaphorin 3A for treatment of systemic lupus erythematosus Grant 10,105,413 - Vadasz , et al. October 23, 2 | 2018-10-23 |
| Semaphorin 3a For Treatment And Assessment Of Severity Of Inflammatory Bowel Disease App 20180028604 - VADASZ; Zahava ; et al. | 2018-02-01 |
| Semaphorin 3a For Treatment And Prognosis Of Systemic Lupus Erythematosus App 20160129079 - VADASZ; Zahava ; et al. | 2016-05-12 |
| Semaphorin 3a For Treatment And Assessment Of Severity Of Asthma App 20150216929 - Vadasz; Zahava ; et al. | 2015-08-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 